Le azioni Gilead Sciences salgono di circa il 3,5% mentre gli investitori si aspettano solidi ...
|
Gilead Sciences guadagna oggi il 3,43%, raggiungendo
$164,55, grazie ai solidi ricavi nei settori HIV e oncologia, in vista
dell'imminente ... |
Italiano — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
